Descrizione
⋅ Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
-Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment
-Extraction-Free, Real-Time PCR Workflow with Capacity of up to 6,000 Tests per Day per System
-Demonstrated 100 Percent Agreement with Authorized Nasopharyngeal Assays
finance.yahoo.com/news/fluidigm-granted-fda-emergency-authorization-030000078.html